Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family

Cellular and Molecular Life Sciences

Volumn 65, Issue 16, 2008, Pages 2541-2553

  Izuhara, K ^a   Ohta, S ^a   Kanaji, S ^a   Shiraishi, H ^a   Arima, K ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Clade B; Cysteine protease; Evolution; Localization; Nuclear serpin; Ov serpin; Secretion; Serpin

Indexed keywords

ASPARTIC PROTEINASE; CYSTEINE PROTEINASE; LEUKOCYTE ELASTASE INHIBITOR; MASPIN; OVALBUMIN SERPIN; PLASMINOGEN ACTIVATOR INHIBITOR 2; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN 1; SQUAMOUS CELL CARCINOMA ANTIGEN 2; UNCLASSIFIED DRUG;

CYTOPLASM; GENETIC ANALYSIS; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; EVOLUTION, MOLECULAR; HUMANS; OVALBUMIN; PEPTIDE HYDROLASES; SERPINS;

EID: 50249142899     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8049-7     Document Type: Review

References (103)

1. Silverman, G. A., Bird, P. I., Carrell, R. W., Church, F. C., Coughlin, P. B., Gettins, P. G., Irving, J. A., Lomas, D. A., Luke, C. J., Moyer, R. W., Pemberton, P. A., Remold-O'Donnell, E., Salvesen, G. S., Travis, J. and Whisstock, J. C. (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293-33296.
2. Gettins, P. G. (2002) Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4804.
3. Silverman, G. A., Whisstock, J. C., Askew, D. J., Pak, S. C., Luke, C. J., Cataltepe, S., Irving, J. A. and Bird, P. I. (2004) Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell. Mol. Life. Sci. 61, 301-325.
4. Remold-O'Donnell, E. (1993) The ovalbumin family of serpin proteins. FEBS Lett. 315, 105-108.
5. Pak, S. C., Kumar, V., Tsu, C., Luke, C. J., Askew, Y. S., Askew, D. J., Mills, D. R., Bromme, D. and Silverman, G. A. (2004) SRP-2 is a cross-class inhibitor that participates in postembryonic development of the nematode Caenorhabditis elegans: initial characterization of the clade L serpins. J. Biol. Chem. 279, 15448-15459.
6. Benarafa, C. and Remold-O'Donnell, E. (2005) The ovalbumin serpins revisited: perspective from the chicken genome of clade B serpin evolution in vertebrates. Proc. Natl. Acad. Sci. USA 102, 11367-11372.
7. Coughlin, P., Nicholl, J., Sun, J., Salem, H., Bird, P. and Sutherland, G. R. (1995) Chromosomal mapping of the human proteinase inhibitor 6 (PI6) gene to 6p25 by fluorescence in situ hybridization. Genomics 26, 431-433.
8. Evans, E., Cooley, J. and Remold-O'Donnell, E. (1995) Characterization and chromosomal localization of ELANH2, the gene encoding human monocyte/neutrophil elastase inhibitor. Genomics 28, 235-240.
9. Eyre, H. J., Sun, J., Sutherland, G. R. and Bird, P. (1996) Chromosomal mapping of the gene (PI9) encoding the intracellular serpin proteinase inhibitor 9 to 6p25 by fluorescence in situ hybridization. Genomics 37, 406-408.
10. Askew, Y. S., Pak, S. C., Luke, C. J., Askew, D. J., Cataltepe, S., Mills, D. R., Kato, H., Lehoczky, J., Dewar, K., Birren, B. and Silverman, G. A. (2001) SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases. J. Biol. Chem. 276, 49320-49330.
11. Bartuski, A. J., Kamachi, Y., Schick, C., Overhauser, J. and Silverman, G. A. (1997) Cytoplasmic antiproteinase 2 (PI8) and bomapin (PI10) map to the serpin cluster at 18q21.3. Genomics 43, 321-328.
12. Kaiserman, D., Knaggs, S., Scarff, K. L., Gillard, A., Mirza, G., Cadman, M., McKeone, R., Denny, P., Cooley, J., Benarafa, C., Remold-O'Donnell, E., Ragoussis, J. and Bird, P. I. (2002) Comparison of human chromosome 6p25 with mouse chromosome 13 reveals a greatly expanded ov-serpin gene repertoire in the mouse. Genomics 79, 349-362.
13. Puente, X. S. and Lopez-Otin, C. (2004) A genomic analysis of rat proteases and protease inhibitors. Genome Res. 14, 609-622.
14. Askew, D. J., Askew, Y. S., Kato, Y., Turner, R. F., Dewar, K., Lehoczky, J. and Silverman, G. A. (2004) Comparative genomic analysis of the clade B serpin cluster at human chromosome 18q21: amplification within the mouse squamous cell carcinoma antigen gene locus. Genomics 84, 176-184.
15. Kaiserman, D. and Bird, P. I. (2005) Analysis of vertebrate genomes suggests a new model for clade B serpin evolution. BMC Genomics 6, 167.
16. Stein, P. E., Tewkesbury, D. A. and Carrell, R. W. (1989) Ovalbumin and angiotensinogen lack serpin S-R conformational change. Biochem. J. 262, 103-107.
17. Becerra, S. P., Sagasti, A., Spinella, P. and Notario, V. (1995) Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J. Biol. Chem. 270, 25992-25999.
18. Hopkins, P. C. and Whisstock, J. (1994) Function of maspin. Science 265, 1893-1894.
19. Askew, D. J., Cataltepe, S., Kumar, V., Edwards, C., Pace, S. M., Howarth, R. N., Pak, S. C., Askew, Y. S., Bromme, D., Luke, C. J., Whisstock, J. C. and Silverman, G. A. (2007) SERPINB11 is a new noninhibitory intracellular serpin. Common single nucleotide polymorphisms in the scaffold impair conformational change. J. Biol. Chem. 282, 24948-24960.
20. Pemberton, P. A., Wong, D. T., Gibson, H. L., Kiefer, M. C., Fitzpatrick, P. A., Sager, R. and Barr, P. J. (1995) The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin. J. Biol. Chem. 270, 15832-15837.
21. Al-Ayyoubi, M., Gettins, P. G. and Volz, K. (2004) Crystal structure of human maspin, a serpin with antitumor properties: reactive center loop of maspin is exposed but constrained. J. Biol. Chem. 279, 55540-55544.
22. Law, R. H., Irving, J. A., Buckle, A. M., Ruzyla, K., Buzza, M., Bashtannyk-Puhalovich, T. A., Beddoe, T. C., Nguyen, K., Worrall, D. M., Bottomley, S. P., Bird, P. I., Rossjohn, J. and Whisstock, J. C. (2005) The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix. J. Biol. Chem. 280, 22356-22364.
23. Stein, P. E., Leslie, A. G., Finch, J. T., Turnell, W. G., McLaughlin, P. J. and Carrell, R. W. (1990) Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature 347, 99-102.
24. Simonovic, M., Gettins, P. G. and Volz, K. (2001) Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor. Proc. Natl. Acad. Sci. USA 98, 11131-11135.
25. Komiyama, T., Ray, C. A., Pickup, D. J., Howard, A. D., Thornberry, N. A., Peterson, E. P. and Salvesen, G. (1994) Inhibition of interleukin-1β converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J. Biol. Chem. 269, 19331-19337.
26. Mathialagan, N. and Hansen, T. R. (1996) Pepsin-inhibitory activity of the uterine serpins. Proc. Natl. Acad. Sci. USA 93, 13653-13658.
27. Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V. M. and Salvesen, G. S. (1997) Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 272, 7797-7800.
28. Quan, L. T., Caputo, A., Bleackley, R. C., Pickup, D. J. and Salvesen, G. S. (1995) Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. 270, 10377-10379.
29. Takeda, A., Yamamoto, T., Nakamura, Y., Takahashi, T. and Hibino, T. (1995) Squamous cell carcinoma antigen is a potent inhibitor of cysteine proteinase cathepsin L. FEBS Lett. 359, 78-80.
30. Schick, C., Pemberton, P. A., Shi, G. P., Kamachi, Y., Cataltepe, S., Bartuski, A. J., Gornstein, E. R., Bromme, D., Chapman, H. A. and Silverman, G. A. (1998) Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 37, 5258-5266.
31. Annand, R. R., Dahlen, J. R., Sprecher, C. A., De Dreu, P., Foster, D. C., Mankovich, J. A., Talanian, R. V., Kisiel, W. and Giegel, D. A. (1999) Caspase-1 (interleukin-1β-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem. J. 342, 655-665.
32. Kummer, J. A., Micheau, O., Schneider, P., Bovenschen, N., Broekhuizen, R., Quadir, R., Strik, M. C., Hack, C. E. and Tschopp, J. (2007) Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosis. Cell Death Differ. 14, 1486-1496.
33. Sun, J., Bird, C. H., Sutton, V., McDonald, L., Coughlin, P. B., De Jong, T. A., Trapani, J. A. and Bird, P. I. (1996) A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem. 271, 27802-27809.
34. Welss, T., Sun, J., Irving, J. A., Blum, R., Smith, A. I., Whisstock, J. C., Pike, R. N., von Mikecz, A., Ruzicka, T., Bird, P. I. and Abts, H. F. (2003) Hurpin is a selective inhibitor of lysosomal cathepsin L and protects keratinocytes from ultraviolet-induced apoptosis. Biochemistry 42, 7381-7389.
35. Jayakumar, A., Kang, Y., Frederick, M. J., Pak, S. C., Henderson, Y., Holton, P. R., Mitsudo, K., Silverman, G. A., EL-Naggar, A. K., Brömme, D. and Clayman, G. L. (2003) Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis. Arch. Biochem. Biophys. 409, 367-374.
36. Sakata, Y., Arima, K., Takai, T., Sakurai, W., Masumoto, K., Yuyama, N., Suminami, Y., Kishi, F., Yamashita, T., Kato, T., Ogawa, H., Fujimoto, K., Matsuo, Y., Sugita, Y. and Izuhara, K. (2004) The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1. J. Biol. Chem. 279, 5081-5087.
37. Ye, S. and Goldsmith, E. J. (2001) Serpins and other covalent protease inhibitors. Curr. Opin. Struct. Biol. 11, 740-745.
38. Huntington, J. A., Read, R. J. and Carrell, R. W. (2000) Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923-926.
39. Masumoto, K., Sakata, Y., Arima, K., Nakao, I. and Izuhara, K. (2003) Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. J. Biol. Chem. 278, 45296-45304.
40. Irving, J. A., Shushanov, S. S., Pike, R. N., Popova, E. Y., Bromme, D., Coetzer, T. H., Bottomley, S. P., Boulynko, I. A., Grigoryev, S. A. and Whisstock, J. C. (2002) Inhibitory activity of a heterochromatin-associated serpin (MENT) against papain-like cysteine proteinases affects chromatin structure and blocks cell proliferation. J. Biol. Chem. 277, 13192-13201.
41. Hwang, S. R., Steineckert, B., Toneff, T., Bundey, R., Logvinova, A. V., Goldsmith, P. and Hook, V. Y. (2002) The novel serpin endopin 2 demonstrates cross-class inhibition of papain and elastase: localization of endopin 2 to regulated secretory vesicles of neuroendocrine chromaffin cells. Biochemistry 41, 10397-10405.
42. Hwang, S. R., Stoka, V., Turk, V. and Hook, V. Y. (2005) The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition. Biochemistry 44, 7757-7767.
43. Kanaji, S., Tanaka, Y., Sakata, Y., Takeshita, K., Arima, K., Ohta, S., Hansell, E. J., Caffrey, C., Mottram, J. C., Lowther, J., Donnelly, S., Stack, C., Kadowaki, T., Yamamoto, K., McKerrow, J. H., Dalton, J. P., Coombs, G. H. and Izuhara, K. (2007) Squamous cell carcinoma antigen 1 is an inhibitor of parasite-derived cysteine proteases. FEBS Lett. 581, 4260-4264.
44. Chuang, T. L. and Schleef, R. R. (1999) Identification of a nuclear targeting domain in the insertion between helices C and D in protease inhibitor-10. J. Biol. Chem. 274, 11194-11198.
45. Bird, C. H., Blink, E. J., Hirst, C. E., Buzza, M. S., Steele, P. M., Sun, J., Jans, D. A. and Bird, P. I. (2001) Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1. Mol. Cell. Biol. 21, 5396-5407.
46. Strik, M. C., Bladergroen, B. A., Wouters, D., Kisiel, W., Hooijberg, J. H., Verlaan, A. R., Hordijk, P. L., Schneider, P., Hack, C. E. and Kummer, J. A. (2002) Distribution of the human intracellular serpin protease inhibitor 8 in human tissues. J. Histochem. Cytochem. 50, 1443-1454.
47. Kawano, T., Morimoto, K. and Uemura, Y. (1970) Partial purification and properties of urokinase inhibitor from human placenta. J. Biochem. 67, 333-342.
48. Medcalf, R. L. and Stasinopoulos, S. J. (2005) The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. FEBS J. 272, 4858-4867.
49. Kruithof, E. K., Baker, M. S. and Bunn, C. L. (1995) Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86, 4007-4024.
50. Kruithof, E. K., Tran-Thang, C., Gudinchet, A., Hauert, J., Nicoloso, G., Genton, C., Welti, H. and Bachmann, F. (1987) Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 69, 460-466.
51. Hibino, T., Matsuda, Y., Takahashi, T. and Goetinck, P. F. (1999) Suppression of keratinocyte proliferation by plasminogen activator inhibitor-2. J. Invest. Dermatol. 112, 85-90.
52. Schleuning, W. D., Medcalf, R. L., Hession, C., Rothenbuhler, R., Shaw, A. and Kruithof, E. K. (1987) Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol. Cell. Biol. 7, 4564-4567.
53. Antalis, T. M., La Linn, M., Donnan, K., Mateo, L., Gardner, J., Dickinson, J. L., Buttigieg, K. and Suhrbier, A. (1998) The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon α/β priming. J. Exp. Med. 187, 1799-1811.
54. Foekens, J. A., Buessecker, F., Peters, H. A., Krainick, U., van Putten, W. L., Look, M. P., Klijn, J. G. and Kramer, M. D. (1995) Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer. Cancer Res. 55, 1423-1427.
55. Yoshino, H., Endo, Y., Watanabe, Y. and Sasaki, T. (1998) Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis. Br. J. Cancer 78, 833-839.
56. Hasina, R., Hulett, K., Bicciato, S., Di Bello, C., Petruzzelli, G. J. and Lingen, M. W. (2003) Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. Cancer Res. 63, 555-559.
57. Jensen, P. H., Lorand, L., Ebbesen, P. and Gliemann, J. (1993) Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Eur. J. Biochem. 214, 141-146.
58. Jensen, P. H., Schuler, E., Woodrow, G., Richardson, M., Goss, N., Hojrup, P., Petersen, T. E. and Rasmussen, L. K. (1994) Aunique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking. J. Biol. Chem. 269, 15394-15398.
59. Jensen, P. H., Jensen, T. G., Laug, W. E., Hager, H., Gliemann, J. and Pepinsky, B. (1996) The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain. J. Biol. Chem. 271, 26892-26899.
60. Darnell, G. A., Antalis, T. M., Johnstone, R. W., Stringer, B. W., Ogbourne, S. M., Harrich, D. and Suhrbier, A. (2003) Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif. Mol. Cell. Biol. 23, 6520-6532.
61. Ye, R. D., Wun, T. C. and Sadler, J. E. (1988) Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U-937 cells. J. Biol. Chem. 263, 4869-4875.
62. Ritchie, H. and Booth, N. A. (1998) Secretion of plasminogen activator inhibitor 2 by human peripheral blood monocytes occurs via an endoplasmic reticulum-golgi-independent pathway. Exp. Cell. Res. 242, 439-450.
63. von Heijne, G., Liljestrom, P., Mikus, P., Andersson, H. and Ny, T. (1991) The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity. J. Biol. Chem. 266, 15240-15243.
64. Palmiter, R. D., Gagnon, J. and Walsh, K. A. (1978) Ovalbumin: a secreted protein without a transient hydrophobic leader sequence. Proc. Natl. Acad. Sci. USA 75, 94 -98.
65. Macaluso, M., Montanari, M., Marshall, C. M., Gambone, A. J., Tosi, G. M., Giordano, A. and Massaro-Giordano, M. (2006) Cytoplasmic and nuclear interaction between Rb family proteins and PAI-2: a physiological crosstalk in human corneal and conjunctival epithelial cells. Cell Death Differ. 13, 1515-1522.
66. Mikus, P. and Ny, T. (1996) Intracellular polymerization of the serpin plasminogen activator inhibitor type 2. J. Biol. Chem. 271, 10048-10053.
67. Wilczynska, M., Lobov, S., Ohlsson, P. I. and Ny, T. (2003) A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization. EMBO J. 22, 1753-1761.
68. Lobov, S., Wilczynska, M., Bergstrom, F., Johansson, L. B. and Ny, T. (2004) Structural bases of the redox-dependent conformational switch in the serpin PAI-2. J. Mol. Biol. 344, 1359-1368.
69. Zou, Z., Anisowicz, A., Hendrix, M. J., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E. and Sager, R. (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263, 526-529.
70. Bailey, C. M., Khalkhali-Ellis, Z., Seftor, E. A. and Hendrix, M. J. (2006) Biological functions of maspin. J. Cell. Physiol. 209, 617-624.
71. Jiang, N., Meng, Y., Zhang, S., Mensah-Osman, E. and Sheng, S. (2002) Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 21, 4089-4098.
72. Zhang, M., Volpert, O., Shi, Y. H. and Bouck, N. (2000) Maspin is an angiogenesis inhibitor. Nat. Med. 6, 196-199.
73. Bass, R., Fernandez, A. M. and Ellis, V. (2002) Maspin inhibits cell migration in the absence of protease inhibitory activity. J. Biol. Chem. 277, 46845-46848.
74. Zou, Z., Gao, C., Nagaich, A. K., Connell, T., Saito, S., Moul, J. W., Seth, P., Appella, E. and Srivastava, S. (2000) p53 regulates the expression of the tumor suppressor gene maspin. J. Biol. Chem. 275, 6051-6054.
75. Luo, J. L., Tan, W., Ricono, J. M., Korchynskyi, O., Zhang, M., Gonias, S. L., Cheresh, D. A. and Karin, M. (2007) Nuclear cytokine-activated IKKa controls prostate cancer metastasis by repressing Maspin. Nature 446, 690-694.
76. Pemberton, P. A., Tipton, A. R., Pavloff, N., Smith, J., Erickson, J. R., Mouchabeck, Z. M. and Kiefer, M. C. (1997) Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface. J. Histochem. Cytochem. 45, 1697-1706.
77. Sood, A. K., Fletcher, M. S., Gruman, L. M., Coffin, J. E., Jabbari, S., Khalkhali-Ellis, Z., Arbour, N., Seftor, E. A. and Hendrix, M. J. (2002)The paradoxical expression of maspin in ovarian carcinoma. Clin. Cancer Res. 8, 2924-2932.
78. Lonardo, F., Li, X., Siddiq, F., Singh, R., Al-Abbadi, M., Pass, H. I. and Sheng, S. (2006) Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. Lung Cancer 51, 31 -39.
79. Latha, K., Zhang, W., Cella, N., Shi, H. Y. and Zhang, M. (2005) Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol. Cell. Biol. 25, 1737-1748.
80. Cella, N., Contreras, A., Latha, K., Rosen, J. M. and Zhang, M. (2006) Maspin is physically associated with β1 integrin regulating cell adhesion in mammary epithelial cells. FASEB J. 20, 1510-1512.
81. Blacque, O. E. and Worrall, D. M. (2002) Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J. Biol. Chem. 277, 10783-10788.
82. Ngamkitidechakul, C., Warejcka, D. J., Burke, J. M., O'Brien, W. J. and Twining, S. S. (2003) Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J. Biol. Chem. 278, 31796-31806.
83. Seftor, R. E., Seftor, E. A., Sheng, S., Pemberton, P. A., Sager, R. and Hendrix, M. J. (1998) maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res. 58, 5681-5685.
84. Biliran, H., Jr. and Sheng, S. (2001) Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res. 61, 8676-8682.
85. Yin, S., Lockett, J., Meng, Y., Biliran, H., Jr., Blouse, G. E., Li, X., Reddy, N., Zhao, Z., Lin, X., Anagli, J., Cher, M. L. and Sheng, S. (2006) Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res. 66, 4173-4181.
86. Sheng, S. (2006) A role of novel serpin maspin in tumor progression: the divergence revealed through efforts to converge. J. Cell. Physiol. 209, 631-635.
87. Al-Ayyoubi, M., Schwartz, B. S. and Gettins, P. G. (2007) Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions. J. Biol. Chem. 282, 19502-19509.
88. Yin, S., Li, X., Meng, Y., Finley, R. L., Jr., Sakr, W., Yang, H., Reddy, N. and Sheng, S. (2005) Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. J. Biol. Chem. 280, 34985-34996.
89. Bailey, C. M., Khalkhali-Ellis, Z., Kondo, S., Margaryan, N. V., Seftor, R. E., Wheaton, W. W., Amir, S., Pins, M. R., Schutte, B. C. and Hendrix, M. J. (2005) Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership. J. Biol. Chem. 280, 34210-34217.
90. Li, X., Yin, S., Meng, Y., Sakr, W. and Sheng, S. (2006) Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res. 66, 9323-9329.
91. Kato, H. and Torigoe, T. (1977) Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40, 1621-1628.
92. Suminami, Y., Kishi, F., Sekiguchi, K. and Kato, H. (1991) Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem. Biophys. Res. Commun. 181, 51-58.
93. Schneider, S. S., Schick, C., Fish, K. E., Miller, E., Pena, J. C., Treter, S. D., Hui, S. M. and Silverman, G. A. (1995) A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc. Natl. Acad. Sci. USA 92, 3147-3151.
94. Schick, C., Kamachi, Y., Bartuski, A. J., Cataltepe, S., Schechter, N. M., Pemberton, P. A. and Silverman, G. A. (1997) Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J. Biol. Chem. 272, 1849-1855.
95. Luke, C., Schick, C., Tsu, C., Whisstock, J. C., Irving, J. A., Bromme, D., Juliano, L., Shi, G. P., Chapman, H. A. and Silverman, G. A. (2000) Simple modifications of the serpin reactive site loop convert SCCA2 into a cysteine proteinase inhibitor: a critical role for the P3′ proline in facilitating RSL cleavage. Biochemistry 39, 7081-7091.
96. Cataltepe, S., Gornstein, E. R., Schick, C., Kamachi, Y., Chatson, K., Fries, J., Silverman, G. A. and Upton, M. P. (2000) Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas. J. Histochem. Cytochem. 48, 113-122.
97. Kato H. (1992) Squamous cell carcinoma antigen In: Serological Cancer Markers (S. Sell, ed.) pp. 437-451, Humana Press, Totowa, NJ
98. Uemura, Y., Pak, S. C., Luke, C., Cataltepe, S., Tsu, C., Schick, C., Kamachi, Y., Pomeroy, S. L., Perlmutter, D. H. and Silverman, G. A. (2000) Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells. Int. J. Cancer 89, 368-377.
99. Izuhara, K., Kanaji, S., Arima, K., Ohta, S. and Shiraishi, H. (in press) Involvement of cysteine protease inhibitors in the defense mechanism against parasites. Med. Chem.
100. Yuyama, N., Davies, D. E., Akaiwa, M., Matsui, K., Hamasaki, Y., Suminami, Y., Yoshida, N. L., Maeda, M., Pandit, A., Lordan, J. L., Kamogawa, Y., Arima, K., Nagumo, F., Sugimachi, M., Berger, A., Richards, I., Roberds, S. L., Yamashita, T., Kishi, F., Kato, H., Arai, K., Ohshima, K., Tadano, J., Hamasaki, N., Miyatake, S., Sugita, Y., Holgate, S. T. and Izuhara, K. (2002) Analysis of novel disease-related genes in bronchial asthma. Cytokine 19, 287-296.
101. Mitsuishi, K., Nakamura, T., Sakata, Y., Yuyama, N., Arima, K., Sugita, Y., Suto, H., Izuhara, K. and Ogawa, H. (2005) The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis. Clin. Exp. Allergy 35, 1327-1333.
102. Katagiri, C., Nakanishi, J., Kadoya, K. and Hibino, T. (2006) Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of c-JUN NH2-terminal kinase. J. Cell. Biol. 172, 983-990.
103. Ong, P. C., McGowan, S., Pearce, M. C., Irving, J. A., Kan, W. T., Grigoryev, S. A., Turk, B., Silverman, G. A., Brix, K., Bottomley, S. P., Whisstock, J. C. and Pike, R. N. (2007) DNA accelerates the inhibition of human cathepsin v by serpins. J. Biol. Chem. 282, 36980-36986.